TOPIC
Vaccine trial
‘Made In India’ Oxford-AstraZeneca vaccine, manufactured by Serum Institute gets emergency use approval
Covishield is manufactured in India by the world's largest vaccine maker Serum Institute of India.
Union Minister Ramdas Athawale gives new slogan for new coronavirus strain
'No corona, corona no', is the new slogan for the mutated coronavirus.
Anil Vij tests positive for Coronavirus days after he joined third phase of vaccine trials: Here is why there is no reason to panic
As Covaxin trial is double blinded, there is 50% chance that Anil Vij got placebo in place of vaccine, and he only received one dose
China injecting unproven coronavirus vaccine to its citizens, forcing them to sign non-disclosure agreements
Chinese officials are injecting three vaccine candidates into workers whom the government considers important
Serum Institute halts trials of Oxford-AstraZeneca coronavirus vaccine in India after DCGI notice
DCGI had asked Serum Institute why it had not informed them about AstraZeneca halting its trials in other countries.
India’s first Chinese coronavirus vaccine, COVAXIN, undergoes human trials: Here are the details
Human trials of indigenously prepared covid-19 vaccine COVAXIN starts across 12 trial centres in India
ICMR refutes claims of unrealistic goal to release COVAXIN, says it is only cutting red tape, not any necessary clinical process
ICMR issues statement saying its expedited trial for Covaxin will bypass only red tape and files, not clinical tests
VHP leader Surendra Jain offers himself for human trials of newly developed coronavirus vaccine COVAXIN
VHP leader Surendra Jain said that he is ready to join human trial for COVAXIN and the institute can him for these trials any time.
Bharat Biotech-ICMR to launch indigenous coronavirus vaccine COVAXIN by August 15
Hyderabad-based Bharat Biotech successfully developed Coronavirus vaccine COVAXIN™ in collaboration with the ICMR and NIV
Bharat Biotech’s potential COVID-19 vaccine ‘Covaxin’ enters clinical trials after DGCI approval
Bharat Biotech gets DGCI's approval for clinical trials of potential Covid-19 vaccine.
